The DOI matches its Crossref record; 64 of the 67 references it cites were found in a registry or an index.
Anti-herpetic Medications and Reduced Risk of Dementia in Patients with Herpes Simplex Virus Infections—a Nationwide, Population-Based Cohort Study in Taiwan
Open accessAbstract
This retrospective cohort study is to investigate the association between herpes simplex virus (HSV) infections and dementia, and the effects of anti-herpetic medications on the risk involved, using Taiwan's National Health Insurance Research Database (NHIRD). We enrolled a total of 33,448 subjects, and identified 8362 with newly diagnosed HSV infections and 25,086 randomly selected sex- and age-matched controls without HSV infections in a ratio of 1:3, selected from January 1, to December 31, 2000. A multivariable Cox proportional hazards regression model was used to evaluate the risk of developing dementia in the HSV cohort. This analysis revealed an adjusted hazard ratio of 2.564 (95% CI: 2.351-2.795, P < 0.001) for the development of dementia in the HSV-infected cohort relative to the non-HSV cohort. Thus, patients with HSV infections may have a 2.56-fold increased risk of developing dementia. A risk reduction of dementia development in patients affected by HSV infections was found upon treatment with anti-herpetic medications (adjusted HR = 0.092 [95% CI 0.079-0.108], P < 0.001). The usage of anti-herpetic medications in the treatment of HSV infections was associated with a decreased risk of dementia. These findings could be a signal to clinicians caring for patients with HSV infections. Further research is, therefore, necessary to explore the underlying mechanism(s) of these associations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“HSV-2 seropositivity has also been associated with decreased memory performance, but appeared to be unrelated to global cognition and other cognitive domains, or the risk of all-cause dementia, AD, vascular dementia and other dementias [27,28].”
From What would it take to prove that a chronic infection is a causal agent in Alzheimer’s disease? (2025) · cites this paper as [28]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredIn the citing paper
“This risk was nearly eliminated in patients that received antiherpetic treatment (Tzeng et al., 2018).”
From Alzheimer Disease: An Update on Pathobiology and Treatment Strategies (2019) · cites this paper as Tzeng et al., 2018
In the citing paper
“One study demonstrated a significantly increased risk of developing all-cause dementia (~3-fold increase) in patients greater than 50 years of age following a new HSV infection.”
From Alzheimer Disease: An Update on Pathobiology and Treatment Strategies (2019) · cites this paper as Tzeng et al., 2018
In the citing paper
“The advent of acyclovir, in the late 1980s, considerably modified the prognosis of HSV-1 encephalitis [54–56].”
From Cognitive decline following acute viral infections: literature review and projections for post-COVID-19 (2022) · cites this paper as [56]
In the citing paper
“Previous research has found that the development of anti-herpes medications had a positive impact, reducing the incidence of AD [56].”
From Cognitive decline following acute viral infections: literature review and projections for post-COVID-19 (2022) · cites this paper as [56]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Daulatzai, M. A. (2016) · Europe PMC (PubMed Central) · Cited by 60
RetractedCharlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
Validation of a combined comorbidity index
Charlson, M., Szatrowski, T. P., Peterson, J., & Gold, J. (1994) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)90129-5 · Cited by 6,587
How to measure comorbiditya critical review of available methods
DEGROOT, V, BECKERMAN, H., LANKHORST, G., & BOUTER, L. (2003) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(02)00585-1 · Cited by 1,757
Epidemiology of Alzheimer disease
Reitz, C., Brayne, C., & Mayeux, R. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.2 · Cited by 1,675
Epidemiology of Alzheimer DiseasePreprint
Mayeux, R. P., & Stern, Y. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006239 · Cited by 1,127
The Alzheimer's Disease-Associated Amyloid β-Protein Is an Antimicrobial Peptide
Soscia, S. J., Kirby, J. E., Washicosky, K. J., Tucker, S. M., Ingelsson, M., Hyman, B., Burton, M. A., Goldstein, L. E., Duong, S., Tanzi, R. E., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009505 · Cited by 1,060
Herpes simplex virus type 1 in brain and risk of Alzheimer's disease
Itzhaki, R. F., Lin, W., Shang, D., Wilcock, G. K., Faragher, B. E., & Jamieson, G. A. (1997) · The Lancet · doi:10.1016/s0140-6736(96)10149-5 · Cited by 671
Gupta, R., Warren, T. J., & Wald, A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61908-4 · Cited by 595
Microbes and Alzheimer’s Disease
Itzhaki, R. F., Lathe, R., Balin, B. J., Ball, M. J., Bearer, E. L., Braak, H., Bullido, M. J., Carter, C., Clerici, M., Cosby, S. L., et al. (2016) · Journal of Alzheimer’s Disease · doi:10.3233/jad-160152 · Cited by 532
Research works printed but not linked: 3
- Tzeng, 2017, The Impact of Pharmacological Treatments on Cognitive Function and Severity of Behavioral Symptoms in Geriatric Elder Patients with Dementia: Pharmacological Treatments on in Elder Patients with Dementia, Taiwanese J Psychiatry., 311, 69
- Daulatzai, 2016, Fundamental Role of Pan-Inflammation and Oxidative-Nitrosative Pathways in Neuropathogenesis of Alzheimer's Disease, Am J Neurodegener Dis., 51, 1
- Kamboh, 1995, Polymorphism and Susceptibility to Alzheimer's Disease, Hum Biol., 672, 195
Cited by
Sorted by citations
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
Long, J. M., & Holtzman, D. M. (2019) · Cell · doi:10.1016/j.cell.2019.09.001 · Cited by 3,204
Eimer, W. A., Vijaya Kumar, D. K., Navalpur Shanmugam, N. K., Rodriguez, A. S., Mitchell, T., Washicosky, K. J., György, B., Breakefield, X. O., Tanzi, R. E., & Moir, R. D. (2018) · Neuron · doi:10.1016/j.neuron.2018.06.030 · Cited by 674
The antimicrobial protection hypothesis of Alzheimer’s disease
Moir, R. D., Lathe, R., & Tanzi, R. E. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.06.3040 · Cited by 456
Alzheimer’s disease: insights into pathology, molecular mechanisms, and therapy
Zheng, Q., & Wang, X. (2024) · Protein & Cell · doi:10.1093/procel/pwae026 · Cited by 483
The amyloid hypothesis on trial
Makin, S. (2018) · Nature · doi:10.1038/d41586-018-05719-4 · Cited by 360
Virus exposure and neurodegenerative disease risk across national biobanks
Levine, K. S., Leonard, H. L., Blauwendraat, C., Iwaki, H., Johnson, N., Bandres-Ciga, S., Ferrucci, L., Faghri, F., Singleton, A. B., & Nalls, M. A. (2023) · Neuron · doi:10.1016/j.neuron.2022.12.029 · Cited by 341
The Impact of Systemic Inflammation on Alzheimer’s Disease Pathology
Xie, J., Van Hoecke, L., & Vandenbroucke, R. E. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.796867 · Cited by 324
Herpes Simplex Virus-1 in the Brain: The Dark Side of a Sneaky Infection
Marcocci, M. E., Napoletani, G., Protto, V., Kolesova, O., Piacentini, R., Li Puma, D. D., Lomonte, P., Grassi, C., Palamara, A. T., & De Chiara, G. (2020) · Trends in Microbiology · doi:10.1016/j.tim.2020.03.003 · Cited by 303
Corroboration of a Major Role for Herpes Simplex Virus Type 1 in Alzheimer’s Disease
Itzhaki, R. F. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00324 · Cited by 256
Unger, M. S., Li, E., Scharnagl, L., Poupardin, R., Altendorfer, B., Mrowetz, H., Hutter-Paier, B., Weiger, T. M., Heneka, M. T., Attems, J., et al. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.05.070 · Cited by 248
Current understanding of the Alzheimer’s disease-associated microbiome and therapeutic strategies
Seo, D.-O., & Holtzman, D. M. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01146-2 · Cited by 259
Morris, G. P., Clark, I. A., & Vissel, B. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1918-8 · Cited by 212
The viral protein corona directs viral pathogenesis and amyloid aggregation
Ezzat, K., Pernemalm, M., Pålsson, S., Roberts, T. C., Järver, P., Dondalska, A., Bestas, B., Sobkowiak, M. J., Levänen, B., Sköld, M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10192-2 · Cited by 209
Drug repositioning and repurposing for Alzheimer disease
Ballard, C., Aarsland, D., Cummings, J., O’Brien, J., Mills, R., Molinuevo, J. L., Fladby, T., Williams, G., Doherty, P., Corbett, A., et al. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0397-4 · Cited by 201
Sipilä, P. N., Heikkilä, N., Lindbohm, J. V., Hakulinen, C., Vahtera, J., Elovainio, M., Suominen, S., Väänänen, A., Koskinen, A., Nyberg, S. T., et al. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(21)00144-4 · Cited by 197
Age-Associated Changes in the Immune System and Blood–Brain Barrier Functions
Erickson, M. A., & Banks, W. A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071632 · Cited by 203
The role of microglia in viral encephalitis: a review
Chen, Z., Zhong, D., & Li, G. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1443-2 · Cited by 196
Do infections have a role in the pathogenesis of Alzheimer disease?
Itzhaki, R. F., Golde, T. E., Heneka, M. T., & Readhead, B. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0323-9 · Cited by 174
Wan, Q., Song, D., Li, H., & He, M. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00233-4 · Cited by 171
Time to test antibacterial therapy in Alzheimer’s disease
Panza, F., Lozupone, M., Solfrizzi, V., Watling, M., & Imbimbo, B. P. (2019) · Brain · doi:10.1093/brain/awz244 · Cited by 161
Periodontal disease as a possible cause for Alzheimer's disease
Kamer, A. R., Craig, R. G., Niederman, R., Fortea, J., & de Leon, M. J. (2020) · Periodontology 2000 · doi:10.1111/prd.12327 · Cited by 159
Multiple Neuroinvasive Pathways in COVID-19
Bougakov, D., Podell, K., & Goldberg, E. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02152-5 · Cited by 142
Warren-Gash, C., Forbes, H. J., Williamson, E., Breuer, J., Hayward, A. C., Mavrodaris, A., Ridha, B. H., Rossor, M. N., Thomas, S. L., & Smeeth, L. (2019) · Scientific Reports · doi:10.1038/s41598-019-41218-w · Cited by 125
Itzhaki, R. F. (2021) · Vaccines · doi:10.3390/vaccines9060679 · Cited by 126
Potential Bidirectional Relationship Between Periodontitis and Alzheimer’s Disease
Liccardo, D., Marzano, F., Carraturo, F., Guida, M., Femminella, G. D., Bencivenga, L., Agrimi, J., Addonizio, A., Melino, I., Valletta, A., et al. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00683 · Cited by 148
The role of the immune system in Alzheimer’s disease
Wu, K., Zhang, Y.-R., Huang, Y., Dong, Q., Tan, L., & Yu, J. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101409 · Cited by 119
Multi-pathogen infections and Alzheimer’s disease
Vigašová, D., Nemergut, M., Lišková, B., & Damborský, J. (2021) · Microbial Cell Factories · doi:10.1186/s12934-021-01520-7 · Cited by 117
Li, H., Liu, C.-C., Zheng, H., & Huang, T. Y. (2018) · Translational Neurodegeneration · doi:10.1186/s40035-018-0139-3 · Cited by 103
Alzheimer’s Disease and Inflammaging
Kosyreva, A., Sentyabreva, A., Tsvetkov, I., & Makarova, O. (2022) · Brain Sciences · doi:10.3390/brainsci12091237 · Cited by 98
Damiano, R. F., Guedes, B. F., de Rocca, C. C., de Pádua Serafim, A., Castro, L. H. M., Munhoz, C. D., Nitrini, R., Filho, G. B., Miguel, E. C., Lucchetti, G., et al. (2022) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-021-01286-4 · Cited by 98
Bae, S., Yun, S.-C., Kim, M.-C., Yoon, W., Lim, J. S., Lee, S.-O., Choi, S.-H., Kim, Y. S., Woo, J. H., Kim, S. Y., et al. (2021) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-020-01157-4 · Cited by 94
Immunotherapies for Aging-Related Neurodegenerative Diseases—Emerging Perspectives and New Targets
Kwon, S., Iba, M., Kim, C., & Masliah, E. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00853-2 · Cited by 97
Vojtechova, I., Machacek, T., Kristofikova, Z., Stuchlik, A., & Petrasek, T. (2022) · PLOS Pathogens · doi:10.1371/journal.ppat.1010929 · Cited by 92
Linking mechanisms of periodontitis to Alzheimer's disease
Sadrameli, M., Bathini, P., & Alberi, L. A. (2020) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000797 · Cited by 93
Infectious hypothesis of Alzheimer disease
Seaks, C. E., & Wilcock, D. M. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008596 · Cited by 93
Viral Involvement in Alzheimer’s Disease
Sait, A. M., Angeli, C., Doig, A. J., & Day, P. J. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00719 · Cited by 90
Park, A.-M., & Tsunoda, I. (2022) · Inflammation and Regeneration · doi:10.1186/s41232-022-00224-8 · Cited by 82
Lopatko Lindman, K., Hemmingsson, E., Weidung, B., Brännström, J., Josefsson, M., Olsson, J., Elgh, F., Nordström, P., & Lövheim, H. (2021) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1002/trc2.12119 · Cited by 99
Chronic effects of inflammation on tauopathies
Langworth-Green, C., Patel, S., Jaunmuktane, Z., Jabbari, E., Morris, H. R., Thom, M., Lees, A. J., Hardy, J., Zandi, M. S., & Duff, K. (2023) · The Lancet Neurology · doi:10.1016/s1474-4422(23)00038-8 · Cited by 85
Are infections seeding some cases of Alzheimer’s disease?
Abbott, A. (2020) · Nature · doi:10.1038/d41586-020-03084-9 · Cited by 82
Olfactory dysfunction in the pathophysiological continuum of dementia
Bathini, P., Brai, E., & Auber, L. A. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100956 · Cited by 77
Human Herpesviruses 6A and 6B in Brain Diseases: Association versus Causation
Komaroff, A. L., Pellett, P. E., & Jacobson, S. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00143-20 · Cited by 77
The intestinal microbiome and Alzheimer's disease: A review
Li, Z., Zhu, H., Zhang, L., & Qin, C. (2018) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12033 · Cited by 78
Dysfunction of the Blood-Brain Barrier—A Key Step in Neurodegeneration and Dementia
Noe, C. R., Noe-Letschnig, M., Handschuh, P. A., Noe, C. A., & Lanzenberger, R. R. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00185 · Cited by 76
The viral hypothesis: how herpesviruses may contribute to Alzheimer’s disease
Wainberg, M., Luquez, T., Koelle, D. M., Readhead, B., Johnston, C., Darvas, M., & Funk, C. C. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01138-6 · Cited by 74
Ribarič, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063245 · Cited by 77
Zou, B., Li, J., Ma, R., Cheng, X.-Y., Ma, R.-Y., Zhou, T.-Y., Wu, Z., Yao, Y., & Li, J. (2023) · Aging and Disease · doi:10.14336/ad.2022.1127 · Cited by 76
Tzeng, N.-S., Chung, C.-H., Chang, C.-C., Chang, H.-A., Kao, Y.-C., Chang, S.-Y., & Chien, W.-C. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-01021-y · Cited by 63
Self-citationModulation of β-Amyloid Fibril Formation in Alzheimer’s Disease by Microglia and Infection
Brown, M. R., Radford, S. E., & Hewitt, E. W. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.609073 · Cited by 67
Herpes Viruses and Senile Dementia: First Population Evidence for a Causal Link
Itzhaki, R. F., & Lathe, R. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180266 · Cited by 63
Amyloid-β: A double agent in Alzheimer's disease?
Yu, H., & Wu, J. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111575 · Cited by 62
Protto, V., Marcocci, M. E., Miteva, M. T., Piacentini, R., Puma, D. D. L., Grassi, C., Palamara, A. T., & Chiara, G. D. (2022) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2022.102200 · Cited by 61
Lindman, K. L., Weidung, B., Olsson, J., Josefsson, M., Kok, E., Johansson, A. S., Eriksson, S., Hallmans, G., Elgh, F., & Lövheim, H. (2019) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1016/j.trci.2019.09.014 · Cited by 60
Apolipoprotein E and viral infection: Risks and Mechanisms
Chen, F., Ke, Q., Wei, W., Cui, L., & Wang, Y. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.07.031 · Cited by 60
Anti-herpetic tau preserves neurons via the cGAS-STING-TBK1 pathway in Alzheimer’s disease
Hyde, V. R., Zhou, C., y Fernández, J. R. M., Chatterjee, K., Ramakrishna, P., Lin, A., Fisher, G. W., Celiker, O. T., Caldwell, J., Bender, O., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2024.115109 · Cited by 61
Viruses in neurodegenerative diseases: More than just suspects in crimes
Leblanc, P., & Vorberg, I. M. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010670 · Cited by 58
Herpes simplex virus and Alzheimer’s disease: a Mendelian randomization study
Kwok, M. K., & Schooling, C. M. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.09.025 · Cited by 55
Herpes simplex virus type 1 and Alzheimer’s disease: link and potential impact on treatment
Mancuso, R., Sicurella, M., Agostini, S., Marconi, P., & Clerici, M. (2019) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2019.1656064 · Cited by 56
Jia, J., Xu, J. L., Liu, J., Wang, Y., Wang, Y., Cao, Y., Guo, Q., Qu, Q.-M., Wei, C., Wei, W., et al. (2021) · Neuroscience Bulletin · doi:10.1007/s12264-021-00701-z · Cited by 62
Lophatananon, A., Carr, M., McMillan, B., Dobson, C. B., Itzhaki, R. F., Parisi, R., Ashcroft, D. M., & Muir, K. R. (2023) · BMC Public Health · doi:10.1186/s12889-023-16768-4 · Cited by 55
Mangold, C. A., & SZPARA, M. L. (2019) · Viruses · doi:10.3390/v11100966 · Cited by 53
McDade, E. (2022) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000001131 · Cited by 56
Antiherpetic medication and incident dementia: Observational cohort studies in four countries
Schnier, C., Janbek, J., Williams, L., Wilkinson, T., Laursen, T. M., Waldemar, G., Richter, H., Kostev, K., Lathe, R., & G Haas, J. (2021) · European Journal of Neurology · doi:10.1111/ene.14795 · Cited by 52
Shin, E., Ah, S., Chung, T., Kim, H. J., Kim, K., & Lim, D. H. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01418-7 · Cited by 49
McFarland, K. N., & Chakrabarty, P. (2022) · Neurotherapeutics · doi:10.1007/s13311-021-01179-3 · Cited by 48
Mechanistic Insights for Drug Repurposing and the Design of Hybrid Drugs for Alzheimer’s Disease
Padhi, D., & Govindaraju, T. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00335 · Cited by 47
Herpes simplex virus 1 and the risk of dementia: a population-based study
Murphy, M. J., Fani, L., Ikram, M. K., Ghanbari, M., & Ikram, M. A. (2021) · Scientific Reports · doi:10.1038/s41598-021-87963-9 · Cited by 46
Yong, S. J., Yong, M. H., Teoh, S. L., Soga, T., Parhar, I. S., Chew, J., & Lim, W. L. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.695738 · Cited by 47
Bruno, F., Malvaso, A., Canterini, S., & Bruni, A. C. (2022) · Antibiotics · doi:10.3390/antibiotics11060726 · Cited by 44
Soluble Amyloid-β Consumption in Alzheimer’s Disease
Espay, A. J., Sturchio, A., Schneider, L. S., & Ezzat, K. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210415 · Cited by 46
Yeh, T.-C., Chien, W.-C., Chung, C.-H., Liang, C.-S., Chang, H.-A., Kao, Y., Yeh, H.-W., Yang, Y.-J., & Tzeng, N.-S. (2020) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2019.12.005 · Cited by 42
Self-citationControversial role of herpesviruses in Alzheimer’s disease
Rizzo, R. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008575 · Cited by 45
Vestin, E., Boström, G., Olsson, J., Elgh, F., Lind, L., Kilander, L., Lövheim, H., & Weidung, B. (2024) · Journal of Alzheimer’s Disease · doi:10.3233/jad-230718 · Cited by 44
Ukraintseva, S. V., Yashkin, A. P., Akushevich, I. V., Arbeev, K. G., Duan, H., Gorbunova, G., Stallard, E., & Yashin, A. I. (2024) · Experimental Gerontology · doi:10.1016/j.exger.2024.112411 · Cited by 47
NLRP3 and Infections: β-Amyloid in Inflammasome beyond Neurodegeneration
Sita, G., Graziosi, A., Hrelia, P., & Morroni, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136984 · Cited by 43
Roles of HSV-1 infection-induced microglial immune responses in CNS diseases: friends or foes?
Wang, Y., Jia, J., Wang, Y., Li, F., Song, X., Qin, S., Wang, Z., Kitazato, K., & Wang, Y. (2019) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2019.1660615 · Cited by 40
Alzheimer’s Amyloid Hypothesis and Antibody Therapy: Melting Glaciers?
Høilund‐Carlsen, P. F., Alavi, A. A., Castellani, R. J., Neve, R. L., Perry, G. L., Revheim, M.-E. R., & Barrio, J. R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073892 · Cited by 44
Laval, K., & Enquist, L. W. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.658695 · Cited by 43
VALZ‐Pilot: High‐dose valacyclovir treatment in patients with early‐stage Alzheimer's disease
Weidung, B., Hemmingsson, E., Olsson, J., Sundström, T., Blennow, K., Zetterberg, H., Ingelsson, M., Elgh, F., & Lövheim, H. (2022) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12264 · Cited by 40
Infectious diseases and cognition: do we have to worry?
Hernández‐Ruiz, V., Letenneur, L., Fülöp, T., Helmer, C., Baudron, C. R., Ávila‐Funes, J. A., & Amieva, H. (2022) · Neurological Sciences · doi:10.1007/s10072-022-06280-9 · Cited by 45
Herpes viruses and Alzheimer's disease: new evidence in the debate
Balin, B. J., & Hudson, A. P. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30316-8 · Cited by 38
Evolving therapeutic interventions for the management and treatment of Alzheimer’s disease
Ahmad, F., Karan, A., Sharma, R., Sharma, N. S., Sundar, V., Jayaraj, R. L., Mukherjee, S., & DeCoster, M. A. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102229 · Cited by 40
Systemic inflammation as a central player in the initiation and development of Alzheimer’s disease
Bayraktaroğlu, I., Ortí-Casañ, N., Dam, D. V., Deyn, P. P. D., & Eisel, U. L. M. (2025) · Immunity & Ageing · doi:10.1186/s12979-025-00529-5 · Cited by 49
What is strain in neurodegenerative diseases?
Tian, Y., Meng, L., & Zhang, Z. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03298-9 · Cited by 37
Qiao, H., Zhao, W., Guo, M., Zhu, L., Chen, T., Wang, J., Xu, X., Zhang, Z., Wu, Y., & Chen, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23115981 · Cited by 43
Self-citationCatumbela, C. S. G., Giridharan, V. V., Barichello, T., & Morales, R. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00369-7 · Cited by 37
Torniainen‐Holm, M., Suvisaari, J., Lindgren, M., Härkänen, T., Dickerson, F., & Yolken, R. H. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.11.016 · Cited by 37
Abrahamson, E. E., Zheng, W., Muralidaran, V., Ikonomović, M. D., Bloom, D. C., Nimgaonkar, V. L., & D’Aiuto, L. (2020) · Journal of Virology · doi:10.1128/jvi.02219-20 · Cited by 39
Can Infections Cause Alzheimer Disease?
Komaroff, A. L. (2020) · JAMA · doi:10.1001/jama.2020.4085 · Cited by 36
Evans, A. K., Defensor, E. B., & Shamloo, M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1030609 · Cited by 40
Giridharan, V. V., Catumbela, C. S. G., Catalão, C. H. R., Lee, J., Ganesh, B. P., Petronilho, F. C., Dal‐Pizzol, F., Morales, R., & Barichello, T. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02172-2 · Cited by 38
Rizzo, R., Bortolotti, D., Gentili, V., Rotola, A., Bolzani, S., Caselli, E., Tola, M. R., & Luca, D. D. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-180777 · Cited by 36
The Role of Genetic, Environmental, and Dietary Factors in Alzheimer’s Disease: A Narrative Review
Mertaş, B., & Boşgelmez, İ. İ. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26031222 · Cited by 35
Immunosenescence as a convergence pathway in neurodegeneration
Mohapatra, L., Mishra, D. K., Tripathi, A. S., & Parida, S. K. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110521 · Cited by 38
Mechanisms and therapeutic potential of interactions between human amyloids and viruses
Michiels, E., Rousseau, F., & Schymkowitz, J. W. H. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03711-8 · Cited by 37
Bocharova, O. V., Pandit, N. P., Molesworth, K., Fisher, A., Mychko, O., Makarava, N., & Baskakov, I. V. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100845 · Cited by 34
Microbes and Alzheimer’s Disease: New Findings Call for a Paradigm Change
Haas, J., & Lathe, R. (2018) · Trends in Neurosciences · doi:10.1016/j.tins.2018.07.001 · Cited by 34
Electroconvulsive Therapy and Risk of Dementia—A Nationwide Cohort Study in Taiwan
Chu, C., Chien, W., Chung, C., Chao, P.-C., Chang, H., Kao, Y., Chou, Y., & Tzeng, N. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00397 · Cited by 33
Self-citationTargeting Infectious Agents as a Therapeutic Strategy in Alzheimer’s Disease
Fülöp, T., Munawara, U., Larbi, A., Desroches, M., Rodrigues, S., Catanzaro, M., Guidolin, A., Khalil, A., Bernier, F., Barron, A. E., et al. (2020) · CNS Drugs · doi:10.1007/s40263-020-00737-1 · Cited by 32
Herpes Zoster Does Not Increase the Risk of Neurodegenerative Dementia: A Case-Control Study
Choi, H. G., Park, B. J., Lim, J. S., Sim, S. Y., Jung, Y. J., & Lee, S. W. (2021) · American Journal of Alzheimer's Disease & Other Dementias® · doi:10.1177/15333175211006504 · Cited by 34
Metadata
- Authors
- Tzeng, N.-S., Chung, C.-H., Lin, F.-H., Chiang, C.-P., Yeh, C.-B., Huang, S.-Y., Lu, R.-B., Chang, H.-A., Kao, Y.-C., Yeh, H.-W., Chiang, W.-S., Chou, Y.-C., Tsao, C.-H., Wu, Y.-F., & Chien, W.-C.
- Affiliations
- Tri-Service General Hospital (TW)
- National Defense Medical Center (TW)
- Tamkang University (TW)
- Corresponding author
- Chien, Wu-Chien
- ORCID
- Venue
- Neurotherapeutics
- Publisher
- Elsevier BV
- Published
- 2018-04
- Volume
- 15
- Issue
- 2
- Pages
- 417-429
- ISSN
- 1878-7479 (ISSN-L)
- PMC
- PMC5935641
- OpenAlex
- W2790037954
- Cited by
- 356
- References
- 67
- Citations by year
- 2026: 34 · 2025: 35 · 2024: 41 · 2023: 40 · 2022: 49 · 2021: 59 · 2020: 48 · 2019: 29 · 2018: 21
- FWCI
- 30.72
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Neurotherapeutics (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Tri-Service General Hospital Research Foundation (TSGH-C105-130, TSGH-C106-002, TSGH-C107-004)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Herpesvirus Infections and Treatments
- Health Sciences › Medicine › Epidemiology › Cytomegalovirus and herpesvirus research
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- herpes simplex, dementia risk, antiviral therapy, neurodegeneration, Taiwan
- MeSH terms
- Aged, Antiviral Agents, Dementia, Female, Herpes Simplex, Humans, Male, Middle Aged, Retrospective Studies, Risk Factors, Taiwan, Proportional Hazards Models
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review